Menu
Back to Journals » Lung Cancer: Targets and Therapy » Volume 2 » default
Lung Cancer: Targets and Therapy
ISSN: 1179-2728
- View all (177)
- Volume 15, 2024 (5)
- Volume 14, 2023 (12)
- Volume 13, 2022 (8)
- Volume 12, 2021 (14)
- Volume 11, 2020 (11)
- Volume 10, 2019 (16)
- Volume 9, 2018 (14)
- Volume 8, 2017 (25)
- Volume 7, 2016 (17)
- Volume 6, 2015 (9)
- Volume 5, 2014 (10)
- Volume 4, 2013 (9)
- Volume 3, 2012 (9)
- Volume 2, 2011 (6)
- Volume 1, 2010 (12)
Archive: Volume 2, 2011
Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancer
Takeda M, Okamoto I, Nishimura Y, Nakagawa K
Lung Cancer: Targets and Therapy 2011, 2:59-67
Published Date: 14 October 2011
Afatinib treatment in advanced non-small cell lung cancer
Hurwitz JL, Scullin P, Campbell L
Lung Cancer: Targets and Therapy 2011, 2:47-57
Published Date: 7 October 2011
Experience with carboplatin and etoposide maintenance chemotherapy in patients with extensive stage small cell lung cancer
Siddiqi A, Bahrain H, Auerbach M
Lung Cancer: Targets and Therapy 2011, 2:41-45
Published Date: 29 August 2011
Effectiveness of maintenance treatments for nonsmall cell lung cancer
Eadens MJ, Robinson SI, Price KA
Lung Cancer: Targets and Therapy 2011, 2:29-39
Published Date: 22 July 2011
Emerging treatment options in the management of non-small cell lung cancer
Filosso PL, Sandri A, Oliaro A, Filippi AR, Cassinis MC, Ricardi U, Lausi P, Asioli S, Ruffini E
Lung Cancer: Targets and Therapy 2011, 2:11-28
Published Date: 8 June 2011
Efficacy and safety of erlotinib in the treatment of metastatic non-small-cell lung cancer
Serena Ricciardi, Silverio Tomao, Filippo de Marinis
Lung Cancer: Targets and Therapy 2011, 2:1-9
Published Date: 20 December 2010